Remmel H. Lawrence
- SEC CIK
- 0001551817
No open-market purchases or sales filed in the past year.
Current role at each company
- ATOS Atossa Therapeutics, Inc.Directoras of May 14, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Remmel H. Lawrence as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2025 (view filing) | Mar 26 | 2 days | Remmel H. LawrenceDirector | PPurchase | +10.0K | $0.70 | +$7.00K | +3,891.1%10.3K after |